What Traditional Chinese Herbal Remedies Are Used for Brain Tumors?

While traditional Chinese medicine (TCM) has long been used as a complementary approach in supportive cancer care, there is no scientifically validated herbal regimen proven to cure or shrink brain tumors. Modern neuro-oncology relies on evidence-based interventions—including maximal safe surgical resection, radiation therapy, and targeted or immunotherapeutic agents—guided by tumor histopathology, molecular profiling (e.g., IDH mutation, MGMT promoter methylation, 1p/19q codeletion), and clinical staging.

Some TCM practitioners may prescribe herbal formulas—such as *Bu Yang Huan Wu Tang* or *Tong Qiao Huo Xue Tang*—to alleviate treatment-related symptoms like fatigue, cognitive fog, or postoperative edema. However, these preparations lack robust clinical trial data demonstrating efficacy against primary or metastatic intracranial neoplasms. Moreover, certain herbs may interact with anticoagulants, anticonvulsants, or corticosteroids commonly used in neuro-oncology, posing potential safety risks.

Patients considering integrative approaches should consult both their neuro-oncologist and a licensed, oncology-trained TCM practitioner. Any herbal therapy must be disclosed to the treating team to avoid pharmacokinetic interactions or delays in guideline-concordant care. Ongoing research into natural compounds—such as berberine or curcumin—is exploring mechanisms of blood–brain barrier penetration and anti-angiogenic activity, but these remain preclinical or early-phase investigational findings.

In summary, while TCM may offer palliative benefits in select patients, it is not a substitute for standard-of-care neuro-oncologic management. Clinical decision-making must prioritize therapies with demonstrated survival benefit, rigorous safety monitoring, and regulatory oversight.